ChromoCure, Inc. (OTCPK: KKUR)
Health Care · Health Care Equipment & Supplies · US
$0.00
— today · 0.0% 1Y
ChromoCure, Inc. (OTCPK: KKUR) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $15.00K and employs 4 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
KKUR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.00K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 17.89
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 15.00B
- Employees
- 4
- Next earnings
- —
About ChromoCure, Inc.
ChromoCure, Inc. specializes in designing and delivering exclusive systems for cancer identification. Their primary offering, the Chromosomal Scanner Series 200, is a detection system capable of identifying a distinct genomic characteristic that is universally present in all cancers yet entirely absent in healthy cells. Furthermore, the company dedicates its scientific and technological expertise to investigating non-toxic and non-invasive strategies for both cancer treatment and cure research. Established in 2001 and based in Reno, Nevada, the organization rebranded as ChromoCure, Inc. in June 2009, having previously been known as Cyberhand Technologies International, Inc.
- ISIN
- US1711271031
- Founded
- 2001
- Listed since
- Apr 27, 2005
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €163.20 | +1.24% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.